AARD
Aardvark Therapeutics, Inc.
NASDAQ · Healthcare · Biotechnology · US
$1.44
−4.64%Leverage
- Debt / equity
- 0.01x
- Net debt / equity
- -0.98x
- Debt / assets
- 0.01x
- Debt / EBITDA
- -0.01x
- Net debt / EBITDA
- 1.05x
Liquidity & coverage
- Current ratio
- 12.63x
- Quick ratio
- 12.63x
- Cash ratio
- 11.57x
- Interest coverage
- —
- EBITDA / interest
- —
- Working capital
- $74.3M
Cash & dividend
- FCF / debt
- -102.53x
- Cash flow / debt
- -102.52x
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- —
Leverage, liquidity, debt coverage and shareholder-distribution metrics · Data as of Jun 1, 2026